首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia
【24h】

Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia

机译:先兆子痫病因中抗血管生成和血管生成因子的平衡

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The "two-stage disorder" theory that is assumed for the etiology of preeclampsia hypothesizes that antiangiogenic and angiogenic factors and/or placental debris play an important role in this disorder. The physiological actions of placental debris occur via the balance between antiangiogenic and angiogenic factors. Accordingly, this balance between antiangiogenic and angiogenic factors should be investigated to elucidate the various pathological features of preeclampsia. Their accurate evaluation is needed to investigate not only antiangiogenic factors (such as sFlt-1 and sEng) and angiogenic factors (such as vascular endothelial growth factor, placental growth factor and transforming growth factor-b) but also the expression level of their receptors such as Flt-1 and Eng. However, it is ethically and technically difficult to investigate the above-mentioned factors at antepartum in human patients. The examination of the ratios of sFlt-1/vascular endothelial growth factor receptor ligands and sEng/transforming vascular endothelial growth factor-b and the use of experimental animal models may help in elucidating various unresolved issues in preeclampsia.
机译:子痫前期病因所假设的“两阶段疾病”理论假设,抗血管生成和血管生成因子和/或胎盘碎片在该疾病中起重要作用。胎盘碎片的生理作用通过抗血管生成和血管生成因子之间的平衡发生。因此,应研究抗血管生成因子和血管生成因子之间的平衡,以阐明先兆子痫的各种病理特征。需要对其进行准确评估,以研究抗血管生成因子(例如sFlt-1和sEng)和血管生成因子(例如血管内皮生长因子,胎盘生长因子和转化生长因子-b),还需要研究其受体的表达水平,例如如Flt-1和Eng。然而,从伦理和技术上来讲,在人类患者的产前调查上述因素是困难的。检查sFlt-1 /血管内皮生长因子受体配体与sEng /转化血管内皮生长因子-b的比率以及使用实验动物模型可能有助于阐明先兆子痫中各种未解决的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号